Showing results (91-100 of 319) with videos related to

Sort By:
Pageof 32
Clinical Lymphoma, Myeloma & Leukemia|February 6, 2018
Pegylated Filgrastim Versus Filgrastim for Stem Cell Mobilization in Multiple Myeloma After Novel Agent InductionMuhammad Bilal Abid, Sanjay De Mel, Muhammad Abbas Abid, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 9, 2025
Matching-Adjusted Indirect Comparison of Daratumumab-Pomalidomide-Dexamethasone and Pomalidomide-Bortezomib-Dexamethasone in Relapsed/Refractory Multiple MyelomaWee Joo Chng, David Bin-Chia Wu, Cathy Kwang-Wei Wu, et al.
Oncotarget|July 13, 2015
Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myelomaChonglei Bi, Tae-Hoon Chung, Gaofeng Huang, et al.
Cell Death & Disease|November 28, 2025
USP13 dictates Ran turnover and vulnerability to ferroptosis in diffuse large B cell lymphoma (DLBCL)Xuan Qiao, Xingmeng Yang, Yuanhao Diao, et al.
Heliyon|November 18, 2024
A systematic review on the epidemiology and treatment options of multiple Myeloma in AsiaWee-Joo Chng, Chandramouli Nagarajan, Shang-Yi Huang, et al.
Oncotarget|December 20, 2017
VS-5584 mediates potent anti-myeloma activity via the upregulation of a class II tumor suppressor gene, RARRES3 and the activation of BimNurulhuda Mustafa, Jeannie Xue Ting Lee, Huey Fang Adina Nee, et al.
Leukemia|November 25, 2018
MMSET I acts as an oncoprotein and regulates GLO1 expression in t(4;14) multiple myeloma cellsZhigang Xie, Jing Yuan Chooi, Sabrina Hui Min Toh, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 24, 2013
Recurrent chromosome abnormalities define nonoverlapping unique subgroups of tumors in patients with chronic lymphocytic leukemia and known karyotypic abnormalitiesVictor H Jimenez-Zepeda, Wee Joo Chng, Roelandt F J Schop, et al.
Oncotarget|February 8, 2014
Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-κB regulated gene products in multiple myeloma xenograft mouse modelKodappully Sivaraman Siveen, Nurulhuda Mustafa, Feng Li, et al.
Oncotarget|August 1, 2013
Plasma membrane proteomics identifies biomarkers associated with MMSET overexpression in T(4;14) multiple myelomaZhigang Xie, Jayantha Gunaratne, Lip Lee Cheong, et al.
Pageof 32